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Taking advantage of the complete genome sequences of several mammals, we developed a novel method to detect
losses of well-established genes in the human genome through syntenic mapping of gene structures between the
human, mouse, and dog genomes. Unlike most previous genomic methods for pseudogene identification, this analysis
is able to differentiate losses of well-established genes from pseudogenes formed shortly after segmental duplication
or generated via retrotransposition. Therefore, it enables us to find genes that were inactivated long after their birth,
which were likely to have evolved nonredundant biological functions before being inactivated. The method was used
to look for gene losses along the human lineage during the approximately 75 million years (My) since the common
ancestor of primates and rodents (the euarchontoglire crown group). We identified 26 losses of well-established genes
in the human genome that were all lost at least 50 My after their birth. Many of them were previously characterized
pseudogenes in the human genome, such as GULO and UOX. Our methodology is highly effective at identifying losses
of single-copy genes of ancient origin, allowing us to find a few well-known pseudogenes in the human genome
missed by previous high-throughput genome-wide studies. In addition to confirming previously known gene losses, we
identified 16 previously uncharacterized human pseudogenes that are definitive losses of long-established genes.
Among them is ACYL3, an ancient enzyme present in archaea, bacteria, and eukaryotes, but lost approximately 6 to 8
Mya in the ancestor of humans and chimps. Although losses of well-established genes do not equate to adaptive gene
losses, they are a useful proxy to use when searching for such genetic changes. This is especially true for adaptive
losses that occurred more than 250,000 years ago, since any genetic evidence of the selective sweep indicative of such
an event has been erased.
Citation: Zhu J, Sanborn JZ, Diekhans M, Lowe CB, Pringle TH, et al. (2007) Comparative genomics search for losses of long-established genes on the human lineage. PLoS
Comput Biol 3(12): e247. doi:10.1371/journal.pcbi.0030247
Introduction
It is intuitive to think that changes leading to increased
complexity, adaptation, and intelligence are achieved by the
gain and improvement of genetic components such as genes
and regulatory elements. However, in certain scenarios, a loss
of function can also bring a selective advantage. The best-
known examples are losses of cell surface receptors to confer
pathogenic resistance, such as the inactivation of the DUFFY
gene contributing to malaria resistance [1] and homozygosity
for a null allele of chemokine receptor CCR5 conveying
resistance to infection by various pathogens, including HIV
[2]. In addition, the loss of an existing biological component
can open new developmental opportunities. The human-
speciﬁc loss of a myosin heavy chain isoform expressed in the
masticatory muscles has been linked to the weakening of
human jaw muscles, possibly allowing the increase of cranial
capacity in humans, although this is still quite speculative [3].
Adaptive gene loss is the type of genetic change that leads to
better ﬁtness for an organism by inactivating a functional
gene. As argued by the ‘‘less-is-more’’ hypothesis, gene losses
may be an important engine of evolutionary innovation [4].
In addition to adaptive evolution, gene losses can play an
important role in human diseases where conditionally
advantageous mutations improve ﬁtness in a particular
environment. For example, deleterious mutations affecting
hemoglobin and other red blood cell proteins are common in
many human populations due to a heterozygote advantage in
malaria epidemic environments. This improved ﬁtness comes
at a cost for those born with deleterious mutations on both
alleles, since the homozygous state causes anemia including
sickle cell disease [5–7]. Other human diseases such as
glucose-6-phosphate dehydrogenase deﬁciency [7] and cystic
ﬁbrosis [8,9] have also been associated with the heterozygote
advantage.
Despite the apparent importance of adaptive gene loss, we
know surprisingly little about its contribution and signiﬁ-
cance at the genomic level and over a broad time scale. Most
research on adaptive evolution in mammals focuses on new
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known genes, such as amino acid substitutions [10,11]. With
the complete genomes of human and several other mammals
including chimp, rhesus, mouse, rat, and dog [12–16], it is
now feasible to systematically identify adaptive gene losses in
t h eh u m a nl i n e a g et h r o u g ht h ec o u r s eo fm a m m a l i a n
evolution.
A claim for adaptive genetic change typically requires
evidence of DNA signatures indicating directional selection,
and is accompanied by the identiﬁcation of selective
pressures acting on the organisms that are consistent with
DNA, fossil, or historical evidence. Methods for detecting
amino acid or DNA signatures left by natural selection are
not generally applicable for identifying adaptive gene loss
[17,18]. An inactivated gene is no longer maintained through
the forces of natural selection, and secondary mutations
begin to accumulate at the neutral rate. Therefore, methods
based on sequence conservation or ratio of synonymous
versus nonsynonymous mutations are not suitable to detect
adaptive gene losses [11,19–21]. Recent adaptive losses can be
detected by the distinct DNA signatures left by positive
selection; however, those signatures only persist for a narrow
evolutionary window of at most 250,000 years [22–24]. To
detect adaptive gene losses further back into the evolutionary
past, it is reasonable to assume that a nonredundant gene that
was functional for a long time and then inactivated is a good
candidate for adaptive gene loss. While not every loss of a
well-established gene is adaptive, searching for those candi-
dates can be used to enrich for adaptive gene losses.
Gene loss normally leaves behind a pseudogene. However,
the vast majority of pseudogenes in a genome did not bring a
selective advantage to the organism. Most pseudogenes arise
through a gene copying operation of either retrotransposi-
tion (reverse-transcribing a processed mRNA back to DNA,
which is reinserted in the genome at a different location) [25],
or by segmental or tandem duplication of a genomic region
[26]. These are called processed or unprocessed pseudogenes,
respectively. While processed pseudogenes in general have a
single exon and a polyadenine tail, unprocessed pseudogenes
typically have multiple exons and preserve the intron–exon
structures of the parental gene. The vast majority of
processed pseudogenes are ‘‘dead on arrival,’’ due to the lack
of complete coding regions or necessary transcription and
translation signals in the new genomic location. Even when a
functional gene is formed by segmental duplication, one copy
often becomes silenced by degenerative mutations due to
functional redundancy [27]. In contrast, adaptive gene losses
arise from degradation of genes with well-established
functions, which often do not have close homologs in the
genome. Taking advantage of the genomic signatures left
behind by retrotransposition or gene duplication, several
genomic surveys identiﬁed tens of thousands of pseudogenes
in the human genome using sequence homology to a
functional parental gene [28–32]. However, because they lack
close homologs, many losses of well-established genes were
missed by these studies. More importantly, these analyses
focused on cataloging pseudogenes in the human genome,
but not on addressing whether the pseudogenizations played
a role in evolution.
This study identiﬁed losses of well-established protein-
coding genes in the human lineage since the common
ancestor of euarchontoglires (primates, lemurs, tree shrews,
rodents, and lagomorphs such as rabbits). We applied a novel
comparative genomic method to identify pseudogenes by
syntenic mapping of gene structures between the human–
mouse–dog trio of genomes. This approach is able to
systematically detect the sequence signature left by losses of
well-established genes, distinguishing true losses from mere
loss of redundant genes following duplication or retrotrans-
position. Our analysis was able to differentiate the losses of
well-established genes from the large background of human
pseudogenes. Twenty six losses of well-established genes were
identiﬁed in the human lineage since the common ancestor
of euarchontoglires, approximately 75 million years ago
(Mya). Sixteen of those were previously uncharacterized gene
losses in the human genome, such as the loss of acyltransfer-
ase 3 during great ape evolution.
Results
Detecting Gene Losses Using Gene Structure
Conservation
After a mutation inactivates a functional gene, the
signature of the intron–exon structure can still be detected
for some time before neutral decay erases it from the
genome. Based on the observation that mammalian gene
structures are typically conserved between species, a gene
prediction program called TransMap was developed that
exploits the large-scale conservation of gene order and
orientation on mammalian chromosomes to map gene
structures between genomes. TransMap is essentially a
cross-species mRNA alignment grogram (Text S1) that relies
upon the ‘‘syntenic’’ alignments produced by the BLASTZ
program [33]. TransMap is highly sensitive in detecting gene
structures for both genes and pseudogenes (Table S2). Unlike
most existing pseudogene detection methods [30,31,34–36],
TransMap does not rely on sequence homology to a parental
gene from the same genome; therefore, it is well-suited for
detecting losses of well-established genes whose functional
precursor has not been recently duplicated. To identify gene
losses, the mapped coding region is conceptually translated
and scanned for ORF-disrupting mutations. A TransMap
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Author Summary
One of the most important questions in biology is to identify the
genetic changes underlying evolution, especially those along the
lineage leading to the modern human. Although counterintuitive,
losing a gene might actually bring a selective advantage to the
organism. This type of gene loss is called adaptive gene loss.
Although a few cases have been characterized in the literature, this
is the first study to address adaptive gene losses on a scale of the
whole human genome and a time period of up to 75 million years.
The difficulty of identifying adaptive gene losses is in part the large
number of pseudogenes in the human genome. To circumvent this
problem, we used two methods to enrich the process for the
adaptive candidates. The first is a novel approach for pseudogene
detection that is highly sensitive in identifying single-copy
pseudogenes that bear no apparent sequence homology to any
functional human genes. Second, we used the length of time a gene
is functional before loss as a proxy for biological importance, which
allows us to differentiate losses of long-established genes from mere
losses due to functional redundancy after gene duplication.
Comparative Genomics Search for Adaptive Gene Lossprediction is a candidate for gene loss if any of the following
ORF-disrupting mutations are detected in the mapped
coding regions: stop codons, frameshifts, a splice junction
that is not GT-AG, or when less than 50% of the coding
region can be mapped to the target (Figure S1). To decrease
the number of false positives, a valid conceptual translation is
required in an outgroup genome. For example, if a mouse
mRNA TransMaps from mouse to the dog genome with a
valid conceptual translation, but fails to do so from mouse to
the human genome, the gene is a candidate for a human gene
loss (Figure 1).
Using mouse mRNAs as queries and the dog genome as an
outgroup, we identiﬁed gene losses in the human lineage
since the common ancestor of euarchontoglires. We chose the
RefSeq database because it is one of the most comprehensive
collections of mouse transcripts [37]. Based on the differ-
ential prediction status in the dog and human genomes, 1,008
of the 19,541 mouse RefSeq transcripts were identiﬁed as
potential human losses (Table S3). The candidates were
reduced to 90 after ﬁltering out overlaps with GenBank
human mRNAs in order to identify pseudogenes where no
transcriptional activity in the form of mature mRNA has been
Figure 1. Algorithm for Identifying Losses of Well-Established Genes in the Human Lineage Since the Common Ancestor of Euarchontoglires
TransMap predicts (pseudo)genes in the human and dog genomes by syntenically mapping mouse mRNA gene structures to the target genomes
through genome alignments and then transferring over the corresponding genomic coordinates. The predicted coding regions are conceptually
translated and scanned for ORF-disrupting mutations. In this example, a stop codon (labeled with an ‘‘*’’) is detected in the first coding exon mapped to
the human genome, which has also experienced an insertion. Genomic insertions or deletions are shown as red rectangles. Of 19,541 mouse RefSeq
genes, 1,008 are identified as initial candidate gene losses in the human lineage based on the differential mutation status in the TransMap results. The
list is narrowed down to 72 after eliminating those overlapping with human transcription evidence and filtered out by a manual inspection. Twenty-six
are identified as losses of well-established genes in the human lineage after analyzing their duplication histories.
doi:10.1371/journal.pcbi.0030247.g001
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Comparative Genomics Search for Adaptive Gene Lossobserved in humans, and to remove the false positive
pseudogenes predicted by TransMap (Text S1). A visual
examination of an alignment of the mouse mRNA sequence,
mouse, human, and dog genomic sequences and their three-
frame translations further reduced the number of candidates
to 72, eliminating 18 that we are not conﬁdent represent true
pseudogenes in the human genome. The pipeline is illus-
trated in Figure 1.
Gene Losses in the Human Lineage
Of the 72 candidates, 27 are predicted to be olfactory
receptors (ORs) and ten are members of large gene families,
such as keratins. These gene families are organized as tandem
gene clusters that have experienced copy number changes
and/or complex local rearrangements since the common
ancestor of euarchontoglires. The dynamics of gene clusters
make it difﬁcult to unambiguously discern ortholog/paralog
relationships among species and analyze the evolutionary
history of the lost genes. Therefore, we focused on the
remaining 35 (non-OR, non-cluster) candidates that were
conﬁrmed by visual inspection, which we referred to as the
‘‘deﬁnite’’ losses in the human lineage. Among them, 21 gene
losses are annotated with some biological functions in mouse
and 14 have not been characterized functionally (Table 1).
The large number of ORs found by this method is
consistent with observations that human OR genes experi-
enced a rapid acceleration of pseudogene formation [38,39].
Previous studies have shown evidence that human genes
involved in olfaction have a signiﬁcant tendency to be under
positive selection, indicating ORs have undergone directional
selection in humans, including by pseudogenization [18,39].
Many previously identiﬁed non-olfactory gene losses were
conﬁrmed as well. These include gulonolactone (L-) oxidase
(GULO), a vitamin C biosynthesis enzyme that is the genetic
basis for scurvy [40], and urate oxidase (UOX), an enzyme
converting uric acid to allantoin [41]. In addition, a human-
speciﬁc nonsense mutation was conﬁrmed in an orphan
chemoattractant G protein–coupled receptor 33 (GPR33).
Additionally, conﬁrmed gene losses included the human-
speciﬁc loss of cardiotrophin-2 (CTF2) due to a 8 bp deletion
[42], cytochrome c oxidase subunit VIIIb (COX8B) with only
40% mapping to the human genome yielding an ORF of eight
amino acids [43], and others listed in Table 1, note a.
Our analysis also identiﬁed 23 previously uncharacterized
losses, of which 21 belong to the deﬁnite loss group and two
are members of complex gene clusters. One example of a
previously unknown deﬁnite loss is acyltransferase 3 (ACYL3;
NM_177028), identiﬁed by the Riken mouse cDNA project
[37,44] and whose function in mammals has not been
characterized experimentally. We conducted protein proﬁle
analysis and determined that this gene has a highly conserved
acyltransferase 3 domain (hence we annotated the gene
ACYL3) [45]. Further structural modeling (SAM, TMHMM,
SignalP) revealed mouse Acyl3 is a multipass transmembrane
protein with its C-terminal domain forming a helix bundle.
The N-terminal is extracellular and hydrophilic with con-
served cysteine residues able to form disulﬁde bonds [46–49].
The extracellular domain might be involved in cellular
response to external signals. Thus, Acyl3 might be a
membrane protein with acyltransferase activity or a multipass
transporter to pass molecules across the membrane upon
external signals [50,51]. Phylogenetically, ACYL3 is ancient
and conserved in archaea, bacteria, fungi, worms, ﬂies, and
mammals. While numerous copies of ACYL3 are encoded in
ﬂy and worm genomes, mammalian genomes have only one
copy. A nonsense mutation (TGG to TGA) located in one of
the transmembrane helices is shared by the human and
chimpanzee genomes. However, the ancestral TGG codon is
present in two orangutan trace sequences, and a valid
conceptual translation is present in the rhesus genome. To
narrow down the timing of the inactivation, we sequenced a
PCR product ampliﬁed from the corresponding region in a
gorilla DNA sample. The sequencing result showed the TGG
(W) codon is present in the gorilla genome. Based on this
evidence, it appears that the nonsense mutation inactivated
ACYL3 after the divergence of gorillas from the human
lineage, and before the divergence of humans and chimpan-
zees (Figure 2). It is intriguing that the last copy of such an
ancient enzyme as ACYL3 was lost during the evolution of
great apes. Although we do not know the precise evolutionary
impact of the loss, its expression pattern in the mouse
pituitary gland and developmental abnormalities observed in
Drosophila null mutants suggests the loss might be related to
development or hormonal regulation [52–54].
As shown in Table 1, other previously unknown gene losses
include CETN4, a mammalian centrin expressed in ciliated
cells including those present in the cerebellum [55], NEPN
(nephrocan), an inhibitor of TGF-b signaling pathway [56],
and NRADD, a death domain containing membrane protein
involved in mediating apoptosis in response to ER stress [57].
It is worth noting that ER-mediated apoptosis triggers a
cascade leading to the activation of Caspase 12 (CASP12), a
gene that is also lost in humans. The loss of CASP12 is still
polymorphic in humans and has been shown to have
experienced a recent selective sweep [58,59].
Timing of the Gene Losses
The timing of the gene losses was determined by ﬁnding
the branch interval that encloses the earliest shared ORF-
disrupting mutations between humans and other mammals
on a phylogenetic tree. The branch intervals on the human
lineage for the 35 deﬁnite losses are illustrated on a
mammalian phylogeny (Figure 3).
Using complete genome sequences of human, chimp,
rhesus, mouse, and dog, six genes were determined to be
human-speciﬁc losses, i.e., lost after the divergence of humans
and chimpanzees. Ten genes were found to be lost during the
period between the human–chimp split and the divergence of
old world monkeys from the human lineage. Among the ten
genes, seven were observed to have independent ORF-
disrupting mutations in the rhesus lineage that are not
shared with humans or chimps. Seventeen genes were
determined to be lost prior to the divergence of old world
monkeys from the human lineage and after the common
ancestor of euarchontoglires. Due to insufﬁcient sequence
information in the rhesus genome, two genes could only be
determined to be lost at some point during the 70 million
years (My) prior to the human–chimp split and after the
common ancestor of euarchontoglires. To reﬁne the timing
of the gene losses, we extracted trace sequences from several
additional primates (orangutan, marmoset, tarsier, galago)
and tree shrew. Using these trace sequences, we were able to
narrow down 50% of gene losses to a much more precise
branch on a phylogenetic tree. For example, the timing of
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Comparative Genomics Search for Adaptive Gene Lossgene losses for GUCY2D, NEPN, and others (number 19 to 22)
was narrowed down to the period of approximately 25 to 40
Mya, between the dates when old world and new world
monkeys split off from the human lineage (Figure 3).
In addition to identifying previously unknown gene losses
in the human genome, our analysis reﬁned the timing of
several previously known gene losses. For example, SULT1D1,
a sulfotransferase, and GSTA4, a glutathione S-transferase
alpha 4 isozyme are known to be pseudogenes in human while
their mouse orthologs remain functional [60,61]; however, it
was unclear when the inactivation occurred. Our analysis
discovered that the pseudogenization of GSTA4 and SULT1D1
occurred approximately 14 to 25 Mya, between the dates
when orangutans and old world monkeys split off from the
human lineage. GULO is known to be inactive in primates
with the inactivation dating to some time prior to the
separation of apes and old world monkeys (.25 Mya) [62].
Frameshift indels, nonsense mutations, and genomic dele-
tions are observed in the human GULO sequence, indicating
an older pseudogene that has experienced numerous secon-
dary mutations. The shared mutation analysis has shown that
human, chimp, rhesus, and marmoset share a nonsense
mutation, while galago, mouse, and dog share the TGG
tryptophan codon. Therefore, the inactivation of GULO
Table 1. Gene Losses in the Human Lineage since the Common Ancestor of Euarchontoglires
Row Mouse Gene Name Annotated Function in Mouse ORF-Disrupting Mutation Note
1 Ctf2 Cardiotrophin 2 8 bp indel a
2 Cyp2g1 Cytochrome P450, family 2, subfamily g Nonsense a
3** Gpr33 G protein-coupled receptor 33 Nonsense a,b
4 1700013G24Rik Adult testis expressed cDNA, a helix-turn-helix domain Nonsense,indel
5** Sord Sorbitol dehydrogenase 1 Indel a
6** S100a15 S100 calcium binding protein A15 46% missing a
7 Acyl3 Acyltransferase 3 Nonsense
8 Crygf Crystallin, gamma F Indel (indel) a, b
9 Taar4 Trace amine-associated receptor 4 Indel a, b
10 Uox Urate oxidase Nonsense a, b
11 Nradd Death domain containing membrane protein Nonsense (indel)
12 Gsta4 Glutathione S-transferase, alpha 4 isozyme Indel (indel) a
13 Sult1d1 Sulfotransferase family 1D, member 1 Nonsense (indel) a, b
14* Pfpl Similar to pore forming protein Indel (indel) b
15 4933429E10Rik Multi antimicrobial extrusion protein (LOC380701) Indel (indel)
16* LOC433492 Vomeromodulin-like protein 40% missing
17 Tex21 Contains leucine zipper motif, expressed in adult testis 35% missing
18 0610012H03Rik Thioesterase superfamily (LOC74088) Indel
19 Gucy2d GC guanylate cyclase 2d receptor Nonsense
20 Nepn Nephrocan Nonsense,indel b
21* BC018465 Contains a lipid-binding serum glycoprotein domain Indel b
22 Gm766 Contains a sulfotransferase domain Indel
23 Gulo Gulonolactone (L-) oxidase 54% missing,indel,nonsense a
24* Abca14 ATP-binding cassette, sub-family A 87% missing a, b
25 Cox8b Cytochrome 8, subunit VIIIb 60% missing (indel) a
26 4921517D21Rik Actin-like domain containing protein SINE insertion
27 BC048502 LOC223927 SINE insertion,indel
28 2700097O09Rik Contains methyltransferases structure (LOC72658) 52% missing
29 2610318N02Rik Contains proline-rich profile (LOC70458) 62% missing
30 D730039F16Rik Contains CutA1 domain (LOC77996) 68% missing
31 B430306N03Rik Immunoglobulin-like protein 80% missing
32** Cxcl7 Pro-platelet basic protein Indel b
33** Unc93a Unc-93 homolog A 88% missing b
34 Cetn4 Centrin 4 Indel
35 Slc7a15 Aromatic-preferring amino acid transporter Nonsense a
þ27 olfactory receptors a, c
þ2 UDP glucuronosyltransferase a, c
þ4 keratin proteins a, c
þ1 cytochrome P450 a, c
þ1 retinol dehydrogenase c
þ1 tryptase a, c
þ1 hypothetical protein similar to putative membrane protein Re9 (2310042E22Rik) c
Among the 72 candidates, after excluding 27 ORs, 35 (numbers 1–35) have been confirmed by visual inspection to be definite losses in the human lineage. The remaining ten genes
belong to large gene families that cluster on the human genome in tandem and had experienced copy number change and/or complex genomic rearrangements since the common
ancestors of euarchontoglires, making it difficult to confirm gene losses by visual inspection. Of the 35 definite losses, 26 are classified as losses of well-established genes (no * label), five
are duplication-induced pseudogenes (labeled with **), and the remaining cannot be determined with the current data set (labeled with *). ORF-disrupting mutations shown in column
four are the earliest shared mutations identified between human and other mammals. Mutations that give rise to an independent gene loss in rhesus are shown in parentheses.
a Previously characterized human gene losses.
b Genes with .60% overlap with pseudogenes from VEGA or Yale pseudogenes [64,65].
c Duplication history as well as ORF-disrupting mutations were undetermined for OR genes and the aforementioned ten genes that belong to tandem gene clusters.
doi:10.1371/journal.pcbi.0030247.t001
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Comparative Genomics Search for Adaptive Gene Lossoccurred before the separation of new world and old world
monkeys (.40 Mya).
Losses of Well-Established Genes versus Duplication-
Induced Pseudogenes
A signiﬁcant contribution of this analysis is to differentiate
losses of well-established genes from the large background of
pseudogenes caused by retrotransposition or formed shortly
after segmental or tandem duplication. The method of
syntenically mapping gene structures to both a target and
outgroup genome is likely to ﬁlter out almost all processed
pseudogenes. However, TransMap does not fully eliminate
those genes that were silenced soon after duplication, which
we referred to as duplication-induced pseudogenes. To
identify duplication-induced gene losses, we need to deter-
mine when the duplication occurred.
Recent segmental duplications can be detected by within-
genome sequence homology. If there is a self-alignment chain
in the UCSC human genome browser [63] enclosing the gene
loss region, the region is determined to have been recently
duplicated. We determined when the duplications had
occurred by tracing along the human lineage through a
seven-species syntenic alignment (human, chimp, rhesus,
mouse, rat, dog, opossum) to determine the origin of each
duplicate in the best self-alignment (the one with the highest
alignment score recorded in the UCSC genome browser). If a
gene and its duplicate trace back to a single region in an
outgroup genome, the duplication was determined to have
occurred on the branch immediately after the outgroup split
off from the human lineage. If the gene and its duplicate
consistently traced back to different regions through the
series of outgroups all the way back to opossum, the
duplication was determined to occur prior to the common
ancestor of human and opossum. Figure 4A is a schematic
illustration of this procedure. The branch of gene duplication
is the branch of gene birth (by duplication).
In many cases, there are no detectable self-alignments,
indicating an ancient duplication had formed the functional
precursor to the pseudogene. We presume the functional
precursor of the pseudogene existed prior to the earliest
common ancestor of human and the species whose genomic
sequence can be aligned to the human exons, therefore
providing a lower bound timing of the gene birth event. To
narrow down the timing of gene birth on the long branch
between dog and opossum, we included scaffold assemblies of
the elephant, tenrec, and armadillo genomes. To infer gene
birth events that occurred further back in the evolutionary
past, we included the chicken genome in the analysis (Figure
4B). Using the above method, the gene birth by duplication
branch for the 35 non-OR, non-cluster deﬁnite gene losses
was determined and is shown in Table 2 (Gene Birth Branch).
Subsequently, we estimated the length of time (in My) a
gene remained functional before its pseudogenization using
the separation of the gene birth and death branches. Since
the timings of both events are estimated as branch intervals,
an upper and lower bound estimation of the separation was
obtained. Using a 50 My threshold, we classiﬁed the
candidates based on their functional time lengths as losses
of well-established genes, duplication-induced pseudogenes,
or undetermined. If the lower estimation of functional time
Figure 2. A Nonsense Mutation Inactivated ACYL3 During Great Ape Evolution
It occurred after the divergence of gorillas from the human lineage and before the human–chimp split. The nonsense mutation is located in exon 13 of
ACYL3. A multispecies syntenic alignment showing the nonsense mutation (‘‘*’’) lies in a highly conserved protein coding region. The stop codon
mutation (TGA) is present in the human and chimp genomes, but a TGG tryptophan (W) codon is present in the rhesus, mouse, rat, dog, and other
mammalian genomes. The region maps to human Chromosome 18 at location 54,881,070–54,881,124. We sequenced the genomic region in a gorilla
DNA sample to show that the codon TGG (W) codon is present in the gorilla genomes.
doi:10.1371/journal.pcbi.0030247.g002
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Comparative Genomics Search for Adaptive Gene Losslength is greater than 50 My, the candidate is classiﬁed as a
loss of a well-established gene. If the upper estimation of
functional time length is smaller than 50 My, the gene loss is
classiﬁed as a duplication-induced pseudogene. The gene loss
is classiﬁed as undetermined if its functional time length
overlaps the 50 My threshold.
Table 2 gives the estimated functional time length for the
35 deﬁnite losses. Among them, 26 are classiﬁed to be losses
of well-established genes, which accounted for the majority
(74%) of the deﬁnite losses. Five are classiﬁed as duplication-
induced losses—CYP2G1, SORD, S100a15, CXCL7, and UN-
C93a— (labeled ‘‘**’’ in Tables 1 and 2). The remaining four
are undetermined. Of these 26 losses of well-established
genes, 16 have not been previously characterized as human
pseudogenes in the literature. Among these 16, four have
been functionally characterized in mouse, which are NRADD,
NEPN, CETN4, and GUCY2D. Table S5 describes various
subsets constructed using the 35 ‘‘deﬁnite’’ losses. All four
candidates do not have detectable homologs in the human
genome. Most strikingly, NRADD, NEPN, and CETN4 re-
mained functional for more than 300 My before being
inactivated.
Discussion
This study presents the ﬁrst attempt to systematically
identify adaptive gene losses in the human genome since the
common ancestor of euarchontoglires, approximately 75
Mya. Using losses of well-established genes as the proxy for
adaptive gene losses, we focused on identifying a class of
pseudogenes that were once functional and retained this
function through tens of millions of years of evolution. We
conﬁdently identiﬁed 26 losses of well-established genes,
including 16 that were not previously known in the literature.
The highlight of this analysis is the ability to automatically
detect losses of genes bearing no signiﬁcant homology to any
functional paralog in the human genome. Their functional
precursors had an ancient origin, but enough evolutionary
time has elapsed to erase any signiﬁcant homology with other
genes in the human genome. These genes were functioning
for hundreds of millions of years and silenced recently within
the past 75 My.
It has been proposed that the majority of pseudogenes are
either dead-on-arrival [58] or inactivated quickly after
duplication [27]. Therefore, it is not surprising that we have
identiﬁed a much smaller number of pseudogenes as
compared to the thousands identiﬁed by previous whole
genome analysis that aimed to catalog the human genome for
unprocessed pseudogenes [30,31,36,64]. We overlapped our
results with two well-known pseudogene databases, Yale
pseudogene database, composed of mostly various computa-
tional predictions [64], and VEGA pseudogene collection,
compiled by manual curation [65]. We found limited overlap
between the losses identiﬁed in Table 1 with both pseudogene
sets (Table S4). Only two out of 31 annotated, zero out of 14
hypothetical, and ﬁve out of 27 ORs were found by all three
analyses. Neither database has GULO, Cardiotropin 2, or
many others listed in Table 1 (see note b). A recent genome
scan identiﬁed 67 human-speciﬁc gene losses, including 36
ORs [58]. Excluding ORs, only one out of the six human-
speciﬁc gene losses identiﬁed in Table 1, Gpr33, was also
discovered in that study [58]. Another possible overlap is
Figure 3. Timing of the Gene Losses in the Human Lineage Since the Common Ancestor of Euarchontoglires, Estimated Based on Shared Mutation
Analysis
Branch intervals enclosing the earliest ORF-disrupting mutations shared between human and other mammals are illustrated on the human lineage of a
mammalian species tree. Genes are represented by numbers, which correspond to their row numbers in Tables 1 and 2. Marks on the rhesus lineage
represent independent ORF-disrupting mutations that are not shared with the ones in the human lineage. Approximate time when the species
diverged from the human lineage is shown in Mya. Species with complete genome sequences are enclosed by rectangles, while others only have trace
sequences available for analysis. Orang.: orangutan; Marm.: marmoset; T.shrew: tree shrew.
doi:10.1371/journal.pcbi.0030247.g003
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Comparative Genomics Search for Adaptive Gene LossUgt2b1, which belongs to a tandem cluster of Ugt2B genes on
Chromosome 4. The limited overlap in part reﬂects the
difference in methodology used to identify the pseudogenes,
but also makes apparent that none of these methods in their
present state are able to form the complete set of losses of
genes with ancient origins. It also conﬁrms that we have
identiﬁed some unprocessed pseudogenes derived from
functional precursors of ancient origin, where evolution has
erased any signiﬁcant homology to their current functional
paralogs.
The gene loss candidates shown in Table 1 are by no means
a complete list of losses of well-established genes in the
human lineage during the past 75 My. TransMap gene model
prediction methodology is not perfect, many factors can
introduce prediction errors including uncertainties in
sequence alignments, errors generated by the gene model
prediction and evaluation procedures, and evolutionary
changes of the gene structures across mammalian species
(Text S1). For example, the well-known human speciﬁc loss of
CMAH (a CMP-sialic acid hydroxylase) [66] was not found by
this analysis due to the strictness of TransMap gene model
predictions, causing a valid CMAH gene model in the dog
genome to be excluded because it featured a noncanonical
GC-AG splice junction. However, the use of an outgroup
genome and the mRNA ﬁlter makes the analysis far more
likely to produce false negatives than false positives. Several
other factors also contribute to this incompleteness. First, our
method using human–mouse–dog comparison relied upon
well-deﬁned mouse genes to seed the search and valid dog
predictions for outgroup conﬁrmation. Problems in either
one will return a false negative result. Our analysis missed
MYH16 because it is not in mouse RefSeq, which could be due
to an independent loss or a misannotation. We further
investigated its absence and found that the MYH16 syntenic
region is not present in the mouse genome, indicating an
independent loss in mouse via genomic deletion. Our analysis
required a valid conceptual translation in the dog genome,
which may fail to occur due to TransMap prediction errors,
sequencing gaps, or an independent loss in dog. However, the
chance of producing a valid mapping increases if multiple
outgroups, such as the opossum genome [67] or a computa-
tionally reconstructed ancestral genome [68], were used and
the resultant gene loss predictions were combined. For
example, the previously documented human speciﬁc loss of
Htr5b [69] can be identiﬁed using a reconstructed boreoeu-
therian genome as the outgroup (Haussler lab, unpublished
data). Our analysis can also be improved by extending our
seed mRNAs to include those from other species and by using
multiple outgroup genomes. For example, using chimpanzee
MYH16 mRNA as a seed could have found this pseudogene in
human.
Our analysis may not identify human polymorphic gene
losses. For example, the human-speciﬁc loss of CASP12 [58,59]
was not identiﬁed by our analysis because the latest human
genome assembly (NCBI release 36) has the functional allele.
Several other human polymorphic losses were also missed by
our analysis for the same reason [70,71]. These polymorphic
null alleles are potentially crucial to human diseases, e.g.,
CASP12 in sepsis and CCR5 in HIV infection. Incorporating
human EST and mRNA information, as was done by Hahn et
al. [70,71], or the human SNP dataset [72], could help our
method identify human polymorphic gene losses. Overlap-
ping those alleles with human disease loci, such as those
documented in OMIM database [73] or identiﬁed by genetic
association studies, might lead to the identiﬁcation of new
human disease associated genes. Another factor that may
cause the method to overlook gene losses is related to
segmental duplication. After a gene is duplicated, both the
Figure 4. Timing of Gene Birth Is Estimated by Determining Duplication Histories of Genomic Regions Surrounding the Gene Losses
For the subset of gene losses with detectable human self-alignment, the duplication branch is determined by tracing each duplicate of the best human
self-alignment through a seven-species syntenic genomic alignment. For those without detectable self-alignments, the duplication branch is
determined by the seven-species syntenic alignments plus alignments with the chicken genome, and the elephant, tenrec, and armadillo scaffolds
when available. Filled rectangles represent syntenic alignment to the human genome, and open rectangles represent genomes or scaffolds aligned to
the human genome without the syntenic constraint. Approximate time when the species diverged from the human lineage is shown in Mya.
doi:10.1371/journal.pcbi.0030247.g004
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the daughter copy (the copy duplicated in the new genomic
context) are equally subject to degenerative mutations. Since
our analysis evaluates based on the status of the ancestral
copy, if evolution silences the daughter copy, it will not be
identiﬁed by our method. However, this type of false negative
is quite limited in our results because it only applies when a
segmental duplication occurred after the boreoeutherian
common ancestor. Treating the daughter copy in the same
way as the ancestral copy will solve this problem, except in
the case of a tandem segmental duplication, where it is
difﬁcult to distinguish the ancestral copy from the daughter
copy.
Among the 26 losses of well-established genes, six were
identiﬁed to be lost independently in the human and old
world monkey lineages (numbers 8, 11, 12, 13, 15, 25 in Table
1). This can be interpreted as a conﬁrmation for adaptive
evolution, if we believe that a common selection pressure
forced these genes to be lost in separate clades. Other known
independent losses such as Caspase15 and Gpr33 seem to
conﬁrm this hypothesis [74,75]. An alternative interpretation
is that the gene function is no longer needed, such as the loss
of GULO in guinea pigs and humans [40]. However, it is also
quite probable that the original loss did not occur independ-
ently on different lineages, but rather a common mutation
that was missed by the analysis might have occurred earlier on
a shared ancestor to inactivate the gene. This might have
been a mutation in a noncoding region, or a mutation that
Table 2. Losses of Well-Established Genes in the Human Genome, Classified Using Estimated Functional Time Length
Row Gene Birth Branch Gene Death Branch Functional Time Length (My) Mouse Gene Name
1 .OP H .134 Ctf2
2** H H 0–6 Cyp2g1
3 .OP H .134 Gpr33
4 .elephant / tenrec H .94 1700013G24Rik
5** H H 0–6 Sord
6** C-R H 0–6 S100a15
7 .OP C–G .132 Acyl3
8 .OP C–O .126 Crygf
9 .OP C–R .115 Taar4
10 .OP C–R .115 Uox
11 .chicken O–R .300 Nradd
12 .elephant O–R .75 Gsta4
13 .elephant O–R .75 Sult1d1
14* M-D O–R 30–71 Pfpl
15 .chicken O–R .300 4933429E10Rik
16* .D R–M .10 LOC433492
17 .OP C–M .115 Tex21
18 .chicken Marm–M .300 0610012H03Rik
19 .elephant./ armadillo R–Marm .60 Gucy2d
20 .chicken R–Marm .300 Nepn
21* .D R–Marm .35 BC018465
22 .chicken R–Marm .300 Gm766
23 .chicken Marm–M .300 Gulo
24* D-OP R–M 10–115 Abca14
25 .chicken C–R .300 Cox8b
26 .tenrec / armadillo R–M .60 4921517D21Rik
27 .elephant R–M .60 BC048502
28 .chicken R–M .300 2700097O09Rik
29 .tenrec R–M .60 2610318N02Rik
30 .chicken R–M .300 D730039F16Rik
31 .armadillo R–M .60 B430306N03Rik
32** R–M R–M 0–50 Cxcl7
33** R–M R–M 0–50 Unc93a
34 .chicken Marm–T.shrew .300 Cetn4
35 .chicken Marm–T.shrew .300 Slc7a15
þ27 olfactory receptors
þ2 UDP glucuronosyltransferase
þ4 keratin proteins
þ1 cytochrome P450 (Cyp4f16)
þ1 retinol dehydrogenase (Rdh7)
þ1 tryptase (Prss32)
þ1 hypothetical protein similar to putative membrane protein Re9 (2310042E22Rik)
The functional time length (in My) of a gene is estimated using the separation between the gene birth branch (duplication branch) and the gene death branch (pseudogenization).
Twenty-six gene losses have lower-bound estimations of their functional time length greater than 50 My and are classified as losses of well-established genes (those not marked with
asterisks), five were alive for less than 50 My and are classified as duplication-induced pseudogenes (labeled with ‘‘**’’). Four are undetermined because their estimated functional time
length overlaps with the 50 My threshold (labeled with ‘‘*’’). H: human; C: chimpanzee; G: gorilla; O: orangutan; R: rhesus; Marm: marmoset; T.shrew: tree shrew; M: mouse; D: dog; OP:
opossum.
doi:10.1371/journal.pcbi.0030247.t002
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For example, a prior, noncoding mutation in any of the six
cases we found could have disrupted the transcription,
translation, or regulatory signals of the gene in the common
ancestor of old world monkeys and apes, rendering the gene
effectively inactive at the time that these lineages split. Since
the gene is no longer under selective pressure to maintain its
integrity, secondary ORF-disrupting mutations could follow,
occurring independently in the separate lineages, as observed
by our analysis.
To identify genes that are truly lost, we have focused on
regions lacking any reported mRNA evidence, including in
cell lines derived from cancer cells. A large number of
candidates with differential mutational status in the human
and dog gene predictions (918 out of 1,008) were ﬁltered out
because they overlap with some mRNA evidence in humans.
The majority of these are likely to be TransMap prediction
errors (Text S1, Table S1). However, some pseudogenes still
generate transcripts if the transcription signal is intact, and
these would be overlooked by our method. An example of a
transcribed pseudogene in the human genome that appears
on this list is CATSPER2 (chr15: 41815434–41825788),
represented by GenBank mRNA BC066967, and BC047442.
The mammalian gene collection annotates it as a transcribed
pseudogene. If a pseudogene is transcribed and spliced, its
mRNA transcript with ORF-disrupting mutations (i.e., pre-
mature stop codon) is targeted and degraded by the cell’s
RNA surveillance pathway of nonsense mediated decay [76],
although this process may not be complete. Only with time
will these pseudogenes will be completely silenced at the level
of transcription. In addition, studies have shown that occa-
sionally a pseudogene, like Makorin1, not only transcribes but
also plays a vital biological role in stabilizing the mRNA of its
homologous coding gene [77]. Thus it is difﬁcult to prove that
a transcribed pseudogene is completely nonfunctional.
Theories of molecular evolution suggest three outcomes
for new genes arising from gene duplication: degeneration
due to functional redundancy, evolution into a new function,
or function sharing by both copies [27]. The expected time
that elapses before a gene is inactivated is thought to be
relatively short [27]. Lynch and Conery estimated the half-life
of a new duplicate to be around 16 My in the human lineage
[27,78,79]. Using this estimate, after our cutoff of 50 My, 11%
of redundant genes caused by duplications are expected to be
intact by chance. After 60 My (the shortest estimation that
passes the cutoff in Table 2), only 7.5% will be left. Twenty-six
candidates in Table 2 are classiﬁed as losses of established
genes using the 50 My cutoff, and many have an estimated
functional period after duplication that is much longer than
50 My. This suggests that they are likely to have evolved
independent functions before pseudogenization and thus
likely to be true losses of well-established genes. In addition,
our method used the lower-bound estimation for the func-
tional time length for this classiﬁcation. Although the higher-
bound estimations for four candidates (PFPL, ABCA14,
LOC344492, BC018465 in Table 2) satisfy the 50 My cutoff,
their low estimations do not. As complete genome sequences
for additional mammals become available in the future, the
timing of duplication and pseudogenization can be greatly
reﬁned, potentially classifying some of these four candidates
as losses of established genes as well.
It is nontrivial to determine whether these losses we have
found were truly adaptive. It is very likely that neutral losses
at dispensable loci account for a subset of our results. For
example, GULO, a vitamin C biosynthesis gene, is thought to
have been lost in primates because primates have ample
dietary supply of ascorbic acid, reducing or removing the
selective pressure that maintains this gene. In general, it is
difﬁcult to differentiate between neutral loss due to removal
of selective pressure, as proposed by the ‘‘use it or lose it
hypothesis,’’ and positively selected adaptive loss, as by the
‘‘less is more’’ hypothesis, without knowing the gene’s precise
biological functions. Given our current knowledge of human
genes, identifying the losses of established genes seem to be
the best strategy in the search for more ancient (before 250
Mya) adaptive gene losses on a genomic scale. The resulting
list is a much more enriched set of candidates.
In summary, our analysis identiﬁed a set of losses that are
highly enriched for well-established genes in the human
genome against a large background of pseudogenes. Expand-
ing these results to include genes and genomes from the
entire mammalian clade will generate a more accurate and
comprehensive picture of adaptive gene losses in human
evolution. From a theoretical standpoint, it will provide
insight into the role that loss of functional genes plays in
evolutionary adaptation [4]. The method presented here can
also be generalized to discover gene losses in other organisms
on a genomic scale.
Materials and Methods
Mapping mouse mRNAs to the human and dog genomes. BLAT
[80] alignments of mouse mRNAs sequences from Genbank [81] and
RefSeq [37] to the cognate genome were obtained from the UCSC
Genome Browser Database [82]. These alignments, along with the
coding sequence annotations associated with the mRNAs, provide
annotations of gene structure in the genome. BLASTZ [33] syntenic
chained alignments [63] of cognate genome (mouse) to the target
genome (human or dog) are used to project the mouse mRNA
alignments to the target genome. This algorithm, known as TransMap
and illustrated in Figure 1, results in predictions of orthologous gene
structures in the target organism. The TransMap prediction method-
ology is described in detail in Text S1.
Sources of sequences, mRNAs, and pseudogene databases.
Genomic sequences used in this study were obtained from the UCSC
genome browser [82]. Sequence release of the following species are
human (NCBI release 36.1; UCSC hg18 March 2006), chimp
(Chimpanzee Sequencing and Analysis Consortium Build 2 version
1; UCSC March 2006), rhesus macaque (BCM HGSC version 1.0,
Mmul_051212; UCSC Jan 2006), mouse (NCBI release 36; UCSC Feb
2006), dog (Broad Institute assembly version 2.0; UCSC May 2005), rat
(Baylor Human Genome Sequencing Center HGSC version 3.4; UCSC
Nov 2004), opossum (draft assembly produced by the Broad Institute;
UCSC Jan 2006), chicken (version 2.1 draft assembly produced by the
Genome Sequencing Center at the Washington University; UCSC May
2006), elephant (Broad Institute version 1.0; UCSC May 2005), tenrec
(Broad Institute echTel 1.0; UCSC Jul 2005), and armadillo (Broad
Institute version 1.0; UCSC May 2005). Trace sequences of orangutan,
marmoset, tarsier, galago, and tree shrew were downloaded from
NCBI Trace Archive. Mouse RefSeq genes were obtained from the
UCSC mouse genome browser, which is consistent with the NCBI
mouse genome build 36.1. Yale and VEGA pseudogene datasets were
also obtained from the UCSC human genome browser track ‘‘Yale
Pseudo’’ and track ‘‘Vega Pseudogenes.’’ Human mRNAs ﬁlter is the
GenBank human mRNAs, obtained from the UCSC human genome
browser track ‘‘Human mRNAs’’. The identiﬁers of the two orangutan
trace sequences used to conﬁrm the TGG (W) codon is present in the
orangutan genome are ti865941905 and ti1012155976 in the NCBI
trace archive.
ACYL3 domain analysis and structural modeling. The mouse gene
ACYL3 (NM_177028) is predicted to contain an acyltransferase 3
(acyl3, IPR002656) and a nose resistant to ﬂuoxetine-4 (NRF,
IPR006621) domain in the InterPro database [45]. We predicted
PLoS Computational Biology | www.ploscompbiol.org December 2007 | Volume 3 | Issue 12 | e247 2507
Comparative Genomics Search for Adaptive Gene LossACYL3 to have eight or nine transmembrane helixes in its C-terminal
sequence using TMHMM v2.0 [48] and to have a 20 amino acid signal
peptide in its N-terminal sequence by SignalP 3.0 [49]. We performed
protein structure modeling using SAM-T05 [46]. SAM (dssp-eh12
model) predicted ACYL3 to be a multi-pass membrane protein with
four conserved cysteine residues in its N-terminal sequence and 12
helixes in its C-terminal sequence. The nonsense stop codon shared
by humans and chimpanzees is located in the tenth helix of the
structural prediction.
DNA ampliﬁcation and sequencing of ACYL3 region in gorilla.
Genomic DNA surrounding the ACYL3 TGG (W) codon was PCR-
ampliﬁed from a gorilla DNA sample. Degenerate PCR primers were
designed based on the conservation in human, chimp, and rhesus
genomic sequences. The forward primer is 59-GGTCACCC-
TATTTGCGGTGGCCGCTCTGGCATACA-39 and the reverse primer
is 59-TGGGCTGGGTCCTCTTTGCGTGCCACNGAGGATATG-
GAGGTATGGA-39. The PCR product was sequenced in both forward
andreversedirections,andresultswerecombinedtogeneratea162bp
gorilla sequence.
Determining earliest shared mutations. The earliest shared
mutations were determined by examining an alignment of genomic
sequences of human, chimp, rhesus, mouse, and dog, plus 200 bp
trace sequences surrounding the mutation site, when available in the
NCBI trace archive, from orangutan, marmoset, tarsier, galago, and
tree shrew. Trace sequence analysis was limited to candidates with
only point mutations (i.e., stop codons, frameshift indels, or
noncanonical splice sites). Candidates with coverage problems
(.50% missing) were only analyzed to check whether the limited
coverage is also shared by the chimp or rhesus genomes, and their
point mutations were not analyzed except for a stop codon mutation
in GULO.
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